Science and Research

Acute Phase Response as a Biological Mechanism-of-Action of (Nano)particle-Induced Cardiovascular Disease

Inhaled nanoparticles constitute a potential health hazard due to their size-dependent lung deposition and large surface to mass ratio. Exposure to high levels contributes to the risk of developing respiratory and cardiovascular diseases, as well as of lung cancer. Particle-induced acute phase response may be an important mechanism of action of particle-induced cardiovascular disease. Here, the authors review new important scientific evidence showing causal relationships between inhalation of particle and nanomaterials, induction of acute phase response, and risk of cardiovascular disease. Particle-induced acute phase response provides a means for risk assessment of particle-induced cardiovascular disease and underscores cardiovascular disease as an occupational disease.

  • Hadrup, N.
  • Zhernovkov, V.
  • Jacobsen, N. R.
  • Voss, C.
  • Strunz, M.
  • Ansari, M.
  • Schiller, H. B.
  • Halappanavar, S.
  • Poulsen, S. S.
  • Kholodenko, B.
  • Stoeger, T.
  • Saber, A. T.
  • Vogel, U.

Keywords

  • C-reactive protein
  • Serum Amyloid A
  • atherosclerosis
  • cardiovascular diseases
  • nanoparticles
  • occupational exposure
Publication details
DOI: 10.1002/smll.201907476
Journal: Small
Pages: e1907476 
Number: 21
Work Type: Review
Location: CPC-M
Disease Area: DPLD
Partner / Member: HMGU
Access-Number: 32227434
See publication on PubMed

DZL Engagements

chevron-down